Geode Capital Management, LLC Greenwich Life Sciences, Inc. Transaction History
Geode Capital Management, LLC
- $1.12 Trillion
- Q2 2024
A detailed history of Geode Capital Management, LLC transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 127,689 shares of GLSI stock, worth $1.72 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
127,689
Previous 58,244
119.23%
Holding current value
$1.72 Million
Previous $1.16 Million
89.75%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding GLSI
# of Institutions
35Shares Held
1.01MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY309KShares$4.15 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA268KShares$3.6 Million0.0% of portfolio
-
Credit Agricole S A87KShares$1.17 Million0.01% of portfolio
-
State Street Corp Boston, MA68.4KShares$919,3360.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny36.9KShares$495,9360.0% of portfolio
About Greenwich LifeSciences, Inc.
- Ticker GLSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,848,200
- Market Cap $173M
- Description
- Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...